Clinical trial
RECOVER-Adult Cycle 2: A Long-Term Follow Up Study of Post-Acute Sequelae of SARS-CoV-2 Infection in Adults
NCT07498504 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- RECOVER-Adult Cycle 2: A Long-Term Follow Up Study of Post-Acute Sequelae of SARS-CoV-2 Infection in Adults
- Lead sponsor
- NYU Langone Health
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- May 31, 2026
- Completion date
- April 30, 2030
- Enrollment
- 5,205 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
long covid, long covid19